TCP-10c Inhibitors
TCP-10c inhibitors are a class of chemical compounds that function by selectively interacting with a specific biological target, known as TCP-10c. This target is typically a protein or enzyme that plays a critical role in certain biochemical pathways within cells. The inhibitors are designed to bind to the TCP-10c with high specificity, meaning they ideally do not interact with other molecules or proteins within the biological system. This selective binding can result in the modulation of the activity of TCP-10c, which can have various downstream effects on cellular processes. The precise mechanism of action of TCP-10c inhibitors depends on the nature of the protein they target and the manner in which they interact with it, which can include altering the protein's conformation, blocking its active site, or interfering with its ability to interact with other cellular components.
The design and development of TCP-10c inhibitors involve detailed knowledge of the structure and function of the target protein. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron microscopy may be used to determine the three-dimensional structure of TCP-10c. With this information, chemists can utilize structure-based drug design to create molecules that fit precisely into the active site or other relevant regions of the protein. Additionally, the pharmacokinetic properties of TCP-10c inhibitors are of significant interest in their development, as these properties determine how the compound behaves within the biological system. Parameters such as solubility, stability, half-life, and metabolic pathways are critical factors in the design of these inhibitors, and they are typically optimized to ensure that the compounds are effective in their selective inhibition of TCP-10c.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K activity can downregulate the AKT signaling pathway, which is often upstream of many growth factors and survival signals that may regulate TCP-10c activity indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 specifically inhibits PI3K, leading to a reduction in AKT phosphorylation. As the AKT pathway influences numerous downstream proteins including those that may control the function or expression of TCP-10c, its inhibition can consequently reduce TCP-10c activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MAP kinase kinase (MEK), which in turn decreases ERK pathway activity. If TCP-10c is influenced by MAPK/ERK signaling, inhibiting this pathway could reduce the functional activity of TCP-10c. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
As a selective inhibitor of both MEK1 and MEK2, U0126 prevents the activation of MAPK/ERK signaling. This could lead to a decrease in the activity of downstream proteins, potentially including TCP-10c if it is regulated by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. By inhibiting p38 MAPK activity, this compound might impact stress response pathways that could influence the function or expression of TCP-10c. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt the mTOR signaling pathway, which is involved in the regulation of cell growth and survival. Inhibition of mTOR could potentially decrease the activity of TCP-10c if TCP-10c is downstream of mTOR signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is implicated in controlling a variety of cellular processes. Inhibition of JNK signaling may decrease the functional activity of TCP-10c if it is modulated by JNK pathway activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a Src family kinase inhibitor that could influence multiple signaling pathways including those regulating cell adhesion, growth, and survival that might indirectly affect TCP-10c activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK). The inhibition of ROCK can lead to changes in cytoskeleton organization and cell motility processes that may indirectly affect the expression or function of TCP-10c. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
PD173074 is a specific inhibitor of the fibroblast growth factor receptor (FGFR) tyrosine kinase. By inhibiting FGFR-mediated signaling pathways, this compound may indirectly decrease the functional activity of TCP-10c if it is associated with FGFR signaling. | ||||||